Uncategorized
Ocular Therapeutix™ Presented Phase 3 Data for DEXTENZA™ at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™ Presented Phase 3 Data for DEXTENZA™ at ARVO Annual Meeting